Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Speak Out Rheum: How the U.K. and U.S. Healthcare Models Stack Up

Chris Deighton, MD  |  Issue: May 2013  |  May 1, 2013

In conclusion, there are big differences in U.S. and U.K. rheumatology, with each having its own strengths and weaknesses. With commissioning of services and increasing involvement of private providers, the U.K. system may be moving more toward a U.S. style of healthcare. Ironically, with the passage of the Affordable Care Act, President Obama seems keen to move the U.S. system more toward an NHS system. Perhaps the best healthcare system lies somewhere in between!


Dr. Deighton is president of the British Society for Rheumatology and a consultant rheumatologist at Royal Derby Hospital, U.K.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Healthcareregulation and legislation

Related Articles

    Rheum’s Role in the New National Health Service

    April 1, 2007

    What the United States can learn from the U.K. system

    Eric Bloodaxe and the Etiology of Paget’s Disease

    October 1, 2009

    The Vikings were in need of a few good rheumatologists

    The Canes of York

    November 1, 2009

    What can a walking stick tell us about U.S. healthcare?

    FDA to Review Immediate-Release Oxycodone; Plus NICE Recommends Secukinumab

    May 1, 2017

    A new formulation of oxycodone in 10 and 15 mg doses is being reviewed by the FDA for treating pain…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences